The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $2.96

Today's change-0.04 -1.17%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $2.96

Today's change-0.04 -1.17%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

VIVUS Inc down (U.S.)$0.04

VIVUS Inc closed lower Friday, dropping (U.S.)$0.04 or 1.17% to (U.S.)$2.96. Over the last five days, shares have lost 10.84% and sit 1.72% above their 52-week low. This security has underperformed the S&P 500 by 81.67% during the last year.

Key company metrics

  • Open(U.S.) $2.99
  • Previous close(U.S.) $3.00
  • High(U.S.) $3.03
  • Low(U.S.) $2.94
  • Bid / Ask-- / --
  • YTD % change-67.40%
  • Volume1,287,443
  • Average volume (10-day)2,494,304
  • Average volume (1-month)1,992,281
  • Average volume (3-month)1,900,917
  • 52-week range(U.S.) $2.91 to (U.S.) $9.80
  • Beta1.13
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.72
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-54.48%

VIVUS Inc has a net profit margin of -54.48%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue34223744
Total other revenue--------
Total revenue34223744
Gross profit27152741
Total cost of revenue77103
Total operating expense42394553
Selling / general / administrative28282937
Research & development3445
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)4028
Other operating expenses, total--------
Operating income-8-17-8-9
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-16-26-16-17
Income after tax-16-26-16-17
Income tax, total0000
Net income-16-26-16-17
Total adjustments to net income--------
Net income before extra. items-16-26-16-17
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-16-26-16-17
Inc. avail. to common incl. extra. items-16-26-16-17
Diluted net income-16-26-16-17
Dilution adjustment0000
Diluted weighted average shares103103103102
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.25-0.15-0.17
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.13-0.25-0.14-0.12